The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Genomics and Health (GA4GH) to aggregate BRCA1 and BRCA2 data to support highly collaborative research activities. Its goal is to generate an informed and current understanding of the impact of genetic variation on cancer risk across the iconic cancer predisposition genes, BRCA1 and BRCA2. Initially, reported variants in BRCA1 and BRCA2 available from public databases were integrated into a single, newly created site, www.brcaexchange.org. The purpose of the BRCA Exchange is to provide the community with a reliable and easily accessible record of variants interpreted for a high-penetrance phenotype. More than 20,000 variants have been aggregated,...
BRCA1 and BRCA2 mutations exhibit variable penetrance that is likely to be accounted for, in part, b...
OBJECTIVES:To report the initial experience of an international group of investigators in identifyin...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
International audienceAs next-generation sequencing increases access to human genetic variation, the...
BRCA Exchange combines information from major public sources to offer a comprehensive view of BRCA v...
Background: Increasing use of BRCA1/2 testing for tailoring cancer treatment and extension of testin...
Objectives: Breast and/or ovarian cancers are complex multifactorial diseases caused by interaction ...
Clinical testing of BRCA1 and BRCA2 began over 20 years ago. With the expiration and overturning of ...
Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisio...
Mutations in two major breast cancer susceptibility genes, BRCA1 and BRCA2, have been identified to ...
Women who carry a pathogenic mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 (BRCA...
Summary BRCA1/2 mutations are the most commonlyidentified germ line gene mutations in patients w...
BRCA1 and BRCA2 mutations exhibit variable penetrance that is likely to be accounted for, in part, b...
OBJECTIVES:To report the initial experience of an international group of investigators in identifyin...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
International audienceAs next-generation sequencing increases access to human genetic variation, the...
BRCA Exchange combines information from major public sources to offer a comprehensive view of BRCA v...
Background: Increasing use of BRCA1/2 testing for tailoring cancer treatment and extension of testin...
Objectives: Breast and/or ovarian cancers are complex multifactorial diseases caused by interaction ...
Clinical testing of BRCA1 and BRCA2 began over 20 years ago. With the expiration and overturning of ...
Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisio...
Mutations in two major breast cancer susceptibility genes, BRCA1 and BRCA2, have been identified to ...
Women who carry a pathogenic mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 (BRCA...
Summary BRCA1/2 mutations are the most commonlyidentified germ line gene mutations in patients w...
BRCA1 and BRCA2 mutations exhibit variable penetrance that is likely to be accounted for, in part, b...
OBJECTIVES:To report the initial experience of an international group of investigators in identifyin...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...